Leopard: A phase II study of post autologous stem cell transplantation (ASCT) maintenance lenalidomide and prednisolone for myeloma (MM), incorporating minimal residual disease (MRD) assessments

Category Primary study
JournalBlood
Year 2013
This article has no abstract
Epistemonikos ID: a8714e8b010f7197392d68cdbe47c81d376e7e28
First added on: Feb 05, 2025